Literature DB >> 32125643

Bacteriophages and Lysins in Biofilm Control.

Marzanna Łusiak-Szelachowska1, Beata Weber-Dąbrowska2,3, Andrzej Górski4,5.   

Abstract

To formulate the optimal strategy of combatting bacterial biofilms, in this review we update current knowledge on the growing problem of biofilm formation and its resistance to antibiotics which has spurred the search for new strategies to deal with this complication. Based on recent findings, the role of bacteriophages in the prevention and elimination of biofilm-related infections has been emphasized. In vitro, ex vivo and in vivo biofilm treatment models with single bacteriophages or phage cocktails have been compared. A combined use of bacteriophages with antibiotics in vitro or in vivo confirms earlier reports of the synergistic effect of these agents in improving biofilm removal. Furthermore, studies on the application of phage-derived lysins in vitro, ex vivo or in vivo against biofilm-related infections are encouraging. The strategy of combined use of phage and antibiotics seems to be different from using lysins and antibiotics. These findings suggest that phages and lysins alone or in combination with antibiotics may be an efficient weapon against biofilm formation in vivo and ex vivo, which could be useful in formulating novel strategies to combat bacterial infections. Those findings proved to be relevant in the prevention and destruction of biofilms occurring during urinary tract infections, orthopedic implant-related infections, periodontal and peri-implant infections. In conclusion, it appears that most efficient strategy of eliminating biofilms involves phages or lysins in combination with antibiotics, but the optimal scheme of their administration requires further studies.

Entities:  

Keywords:  Antibiotics; Bacteriophages; Biofilm; Chronic diseases; Lysins

Mesh:

Substances:

Year:  2020        PMID: 32125643      PMCID: PMC7198674          DOI: 10.1007/s12250-019-00192-3

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  48 in total

1.  Potential of bacteriophages and their lysins in the treatment of MRSA: current status and future perspectives.

Authors:  Jan Borysowski; Małgorzata Lobocka; Ryszard Międzybrodzki; Beata Weber-Dabrowska; Andrzej Górski
Journal:  BioDrugs       Date:  2011-12-01       Impact factor: 5.807

2.  Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus.

Authors:  Peter Sass; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

3.  Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus.

Authors:  Tamta Tkhilaishvili; Lisa Lombardi; Ann-Brit Klatt; Andrej Trampuz; Mariagrazia Di Luca
Journal:  Int J Antimicrob Agents       Date:  2018-09-17       Impact factor: 5.283

Review 4.  Bacteriophage endolysins as a novel class of antibacterial agents.

Authors:  Jan Borysowski; Beata Weber-Dabrowska; Andrzej Górski
Journal:  Exp Biol Med (Maywood)       Date:  2006-04

5.  Recombinant Expression of a Putative Amidase Cloned from the Genome of Listeria monocytogenes that Lyses the Bacterium and its Monolayer in Conjunction with a Protease.

Authors:  Mustafa Simmons; Cesar A Morales; Brian B Oakley; Bruce S Seal
Journal:  Probiotics Antimicrob Proteins       Date:  2012-03       Impact factor: 4.609

6.  Efficient Killing of Planktonic and Biofilm-Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128.

Authors:  Nethravathi Poonacha; Sandhya Nair; Srividya Desai; Darshan Tuppad; Deepika Hiremath; Thulasi Mohan; Aradhana Vipra; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

7.  Phage Therapy - Everything Old is New Again.

Authors:  Andrew M Kropinski
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

8.  Evaluation of Bacteriophage Anti-Biofilm Activity for Potential Control of Orthopedic Implant-Related Infections Caused by Staphylococcus aureus.

Authors:  Jodie Morris; Natasha Kelly; Lisa Elliott; Andrea Grant; Matthew Wilkinson; Kaushik Hazratwala; Peter McEwen
Journal:  Surg Infect (Larchmt)       Date:  2018-09-12       Impact factor: 2.150

9.  'Get in Early'; Biofilm and Wax Moth (Galleria mellonella) Models Reveal New Insights into the Therapeutic Potential of Clostridium difficile Bacteriophages.

Authors:  Janet Y Nale; Mahananda Chutia; Philippa Carr; Peter T Hickenbotham; Martha R J Clokie
Journal:  Front Microbiol       Date:  2016-08-31       Impact factor: 5.640

10.  Characterization of a New Staphylococcus aureus Kayvirus Harboring a Lysin Active against Biofilms.

Authors:  Luís D R Melo; Ana Brandão; Ergun Akturk; Silvio B Santos; Joana Azeredo
Journal:  Viruses       Date:  2018-04-07       Impact factor: 5.048

View more
  18 in total

1.  A Novel Phage Indirectly Regulates Diatom Growth by Infecting a Diatom-Associated Biofilm-Forming Bacterium.

Authors:  Shailesh Nair; Chengcheng Li; Shanli Mou; Zenghu Zhang; Yongyu Zhang
Journal:  Appl Environ Microbiol       Date:  2022-01-12       Impact factor: 5.005

Review 2.  Novel Strategies to Combat Bacterial Biofilms.

Authors:  Fatemeh Hemmati; Mohammad Ahangarzadeh Rezaee; Saba Ebrahimzadeh; Leila Yousefi; Roghayeh Nouri; Hossein Samadi Kafil; Pourya Gholizadeh
Journal:  Mol Biotechnol       Date:  2021-04-29       Impact factor: 2.695

Review 3.  Ways to control harmful biofilms: prevention, inhibition, and eradication.

Authors:  Wen Yin; Siyang Xu; Yiting Wang; Yuling Zhang; Shan-Ho Chou; Michael Y Galperin; Jin He
Journal:  Crit Rev Microbiol       Date:  2020-12-28       Impact factor: 7.624

4.  Antibiofilm Activity of a Broad-Range Recombinant Endolysin LysECD7: In Vitro and In Vivo Study.

Authors:  Mikhail V Fursov; Radmila O Abdrakhmanova; Nataliia P Antonova; Daria V Vasina; Anastasia D Kolchanova; Olga A Bashkina; Oleg V Rubalsky; Marina A Samotrueva; Vasiliy D Potapov; Valentine V Makarov; Sergey M Yudin; Alexander L Gintsburg; Artem P Tkachuk; Vladimir A Gushchin; Evgenii O Rubalskii
Journal:  Viruses       Date:  2020-05-15       Impact factor: 5.048

5.  Synergistic action of phage phiIPLA-RODI and lytic protein CHAPSH3b: a combination strategy to target Staphylococcus aureus biofilms.

Authors:  Ana Catarina Duarte; Lucía Fernández; Vincent De Maesschalck; Diana Gutiérrez; Ana Belén Campelo; Yves Briers; Rob Lavigne; Ana Rodríguez; Pilar García
Journal:  NPJ Biofilms Microbiomes       Date:  2021-04-22       Impact factor: 7.290

6.  Lytic Bacteriophage EFA1 Modulates HCT116 Colon Cancer Cell Growth and Upregulates ROS Production in an Enterococcus faecalis Co-culture System.

Authors:  Mwila Kabwe; Terri Meehan-Andrews; Heng Ku; Steve Petrovski; Steven Batinovic; Hiu Tat Chan; Joseph Tucci
Journal:  Front Microbiol       Date:  2021-03-31       Impact factor: 5.640

Review 7.  The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?

Authors:  Ahmad Y Hassan; Janet T Lin; Nicole Ricker; Hany Anany
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-28

Review 8.  Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?

Authors:  Prasanth Manohar; Belinda Loh; Sudarsanan Athira; Ramesh Nachimuthu; Xiaoting Hua; Susan C Welburn; Sebastian Leptihn
Journal:  Front Microbiol       Date:  2020-06-26       Impact factor: 5.640

9.  Improving Phage-Biofilm In Vitro Experimentation.

Authors:  Stephen T Abedon; Katarzyna M Danis-Wlodarczyk; Daniel J Wozniak; Matthew B Sullivan
Journal:  Viruses       Date:  2021-06-19       Impact factor: 5.048

Review 10.  Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria.

Authors:  Janaína Teixeira Costa de Pontes; Anna Beatriz Toledo Borges; Cesar Augusto Roque-Borda; Fernando Rogério Pavan
Journal:  Pharmaceutics       Date:  2022-03-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.